Search
Viatris Inc
VTRSAdd to Watchlist
17.635USD
+0.395+2.29%
Close 07-27 16:00（ET）Quotes delayed by 15 min
20.30BMarket Cap
LossP/E TTM
More Details of Viatris Inc Company
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. It produces oral solid doses, injectables, and products with complex dosage forms.
Viatris Inc Info
Ticker SymbolVTRS
Company nameViatris Inc
IPO dateFeb 01, 1973
CEOSmith (Scott A)
Number of employees32000
Security typeOrdinary Share
Fiscal year-endFeb 01
Address1000 Mylan Boulevard
CityCANONSBURG
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code15317
Phone17245141465
Websitehttps://www.viatris.com/en
Ticker SymbolVTRS
IPO dateFeb 01, 1973
CEOSmith (Scott A)
Company Executives of Viatris Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Rajiv Malik
Mr. Rajiv Malik
Director
Director
1.07M
--
Mr. Brian Roman
Mr. Brian Roman
Chief Legal Officer
Chief Legal Officer
327.96K
+40.87%
Mr. Paul B. Campbell
Mr. Paul B. Campbell
Chief Accounting Officer, Corporate Controller
Chief Accounting Officer, Corporate Controller
316.53K
-15.82%
Mr. Andrew Enrietti
Mr. Andrew Enrietti
Chief Administrative and Transformation Officer
Chief Administrative and Transformation Officer
219.68K
--
Mr. Richard A. Mark, CPA
Mr. Richard A. Mark, CPA
Independent Director
Independent Director
116.14K
+21.38%
Mr. Wyllie Don Cornwell
Mr. Wyllie Don Cornwell
Independent Director
Independent Director
112.04K
+28.29%
Ms. Theodora (Doretta) Mistras
Ms. Theodora (Doretta) Mistras
Chief Financial Officer
Chief Financial Officer
70.64K
+49.26%
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
62.67K
+39.63%
Dr. Michael E. Severino, M.D.
Dr. Michael E. Severino, M.D.
Independent Director
Independent Director
26.03K
--
Mr. David S. Simmons
Mr. David S. Simmons
Independent Director
Independent Director
24.53K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Rajiv Malik
Mr. Rajiv Malik
Director
Director
1.07M
--
Mr. Brian Roman
Mr. Brian Roman
Chief Legal Officer
Chief Legal Officer
327.96K
+40.87%
Mr. Paul B. Campbell
Mr. Paul B. Campbell
Chief Accounting Officer, Corporate Controller
Chief Accounting Officer, Corporate Controller
316.53K
-15.82%
Mr. Andrew Enrietti
Mr. Andrew Enrietti
Chief Administrative and Transformation Officer
Chief Administrative and Transformation Officer
219.68K
--
Mr. Richard A. Mark, CPA
Mr. Richard A. Mark, CPA
Independent Director
Independent Director
116.14K
+21.38%
Mr. Wyllie Don Cornwell
Mr. Wyllie Don Cornwell
Independent Director
Independent Director
112.04K
+28.29%
FAQs
Who are the top five shareholders of Viatris Inc?
The top five shareholders of Viatris Inc are: Mr. Rajiv Malik
How many institutions hold shares of Viatris Inc (VTRS)?
As of 2026Q1, 1992 institutions hold shares of Viatris Inc, with a combined market value of approximately 1.01B, accounting for 86.70% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -70294858.00.
What is the biggest source of revenue for Viatris Inc?
In 2026Q1, the Brands business generated the highest revenue for Viatris Inc, amounting to 9.18B and accounting for 64.45% of total revenue.